.

Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 073107

« Back to Dashboard
NDA 073107 describes ACETAMINOPHEN, which is a drug marketed by Ohm Labs, Paddock Llc, Sun Pharm Inds Ltd, Able, Perrigo New York, Roxane, Taro Pharms North, Sandoz Inc, Fresenius Kabi Usa, Perrigo, Aurolife Pharma Llc, Vintage, Wockhardt, Warner Chilcott, Whiteworth Town Plsn, Pharm Assoc, Everylife, Sandoz, Hi Tech Pharma, Mallinckrodt Inc, Usl Pharma, Duramed Pharms Barr, Teva, Vintage Pharms, Mikart, Lederle, Watson Labs Florida, Halsey, Mutual Pharm, Superpharm, Actavis Mid Atlantic, Puracap Pharm, Kv Pharm, Frontida Biopharm, Watson Labs, Vitarine, Am Therap, Amneal Pharms Ny, Purepac Pharm, Valeant Pharm Intl, Dava Pharms Inc, Cent Pharms, Gavis Pharms, Boca Pharma Llc, West-ward Pharm Corp, and Wraser Pharms Llc, and is included in one hundred and eighteen NDAs. It is available from sixty-three suppliers. Additional details are available on the ACETAMINOPHEN profile page.

The generic ingredient in ACETAMINOPHEN is acetaminophen; caffeine; dihydrocodeine bitartrate. There are sixty-four drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the acetaminophen; caffeine; dihydrocodeine bitartrate profile page.

Summary for NDA: 073107

Tradename:
ACETAMINOPHEN
Applicant:
Able
Ingredient:
acetaminophen
Patents:0
Formulation / Manufacturing:see details

Summary for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:SUPPOSITORY;RECTALStrength325MG
Approval Date:Feb 27, 1995TE:RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

`abc